Application no. and date | 06752445.4 (espacenet) (Federated) (European Patent Register), 20060510 | Patent/reg. no. and date | DK/EP 1885187, 20130925 | Publication date | 20080213 | Priority no. and date | US 680722 P, 20050513 | EP pub. no. and date |
EP 1885187 20080213 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | NGC/AP/147750 | Inventor | MICHELSON, Glenn C., c/o Novartis AG Post Office Box 8097
Emeryville, California 94662-8097, US, CHAN, Vivien W., c/o Novartis AG Post Office Box 8097
Emeryville, California 94662-8097, US, HEISE, Carla C., c/o Novartis AG Post Office Box 8097
Emeryville, California 94662-8097, US, WIESMANN, Marion, c/o Novartis AG Post Office Box 8097
Emeryville, California 94662-8097, US, DAWES, Timothy D., c/o Novartis AG Post Office Box 8097
Emeryville, California 94662-8097, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/4184 (2006.01) , A61K 31/4425 (2006.01) , A61K 31/497 (2006.01) , A61K 35/00 (2006.01) | Title | Fremgangsmåde til behandling af lægemiddelresistent cancer | Int. application no. | US2006017922 | Int. publication no. | WO2006124413 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|